Presentation TCT 2025 Luna™ TMVR: 28-French Transseptal TMVR System: Technology Description and Early Clinical Results Presenter: Azeem Latib October 27, 2025
Presentation TCT 2025 Real-World Data from Data Aggregators: Opportunities and Challenges Presenter: Ryan Ahern October 27, 2025
Presentation TCT 2025 AI-Powered Clinical Video Platform: Transforming Procedural Data into Actionable Intelligence (AI-Medinbox) Presenter: Nicolas Gausserand October 27, 2025
Presentation TCT 2025 Trans-Apical Intrepid TMVR System: Long Term (5-Year) Technical and Clinical Results Presenter: Michael J. Reardon October 27, 2025
Presentation TCT 2025 TCT 759: Use of Amiodarone for Prevention of New-Onset Atrial Fibrillation after Transcatheter Aortic Valve Replacement: PAF-TAVR Randomized Clinical Trial Presenter: Gabriela Tirado-Conte October 27, 2025
Presentation TCT 2025 TCT 39: Hypo-Attenuated Leaflet Thickening After Transcatheter Tricuspid Valve Replacement: A Proposed Severity Scale and Clinical Correlates Presenter: Hannah Kempton October 27, 2025
Presentation TCT 2025 Hybrid Trial Designs and Real-World Evidence: Will They Ever Be Prime Time? Presenter: Robert W. Yeh October 27, 2025
Presentation TCT 2025 HighLife TMVR System: Long-Term (3-Year) Clinical Outcomes and Valve Performance of the Presenter: Wolfgang Rottbauer October 27, 2025
Presentation TCT 2025 Rational Dispersion of Novel Technologies & the Need for Additional Evidence Generation: Lessons Learned from Recent CMS NCDs Presenter: Sreekanth Vemulapalli October 27, 2025
Presentation TCT 2025 Linkage of Clinical Trial Evidence with Administrative Claims: Pros and Cons Presenter: Eric A. Secemsky October 27, 2025
Presentation TCT 2025 TCT 866: Impact of Tricuspid Regurgitation on Clinical Outcomes in Patients with Mitral Annular Calcification Presenter: Mohanad Hamandi October 27, 2025
Presentation TCT 2025 DragonFly: Technology Description and Clinical Results Presenter: Jian'an Wang October 27, 2025
Presentation TCT 2025 Coordinating ARC Event Definition in Cardiogenic Shock: pVAD, MCS, Adult ECMO, and Beyond Presenter: Jeffrey Popma October 27, 2025
Presentation TCT 2025 TCT 968: Impella vs. IABP in High-Risk PCI Without Cardiogenic Shock: A Systematic Review and Meta-Analysis of Clinical Outcomes Presenter: AHMED K. ABDELRAHMAN October 27, 2025
Presentation TCT 2025 TCT 863: Clinical Profile and Outcomes of Patients Deemed Ineligible for Transcatheter Tricuspid Valve Intervention Presenter: Chloe Kharsa October 27, 2025
Presentation TCT 2025 JensClip: Technology Description and Clinical Results Presenter: Vinicius Esteves October 27, 2025
Presentation TCT 2025 Swimming with the SHARCs: Advancing Harmonization of Definitions Used in Clinical Trials of Cardiogenic Shock Presenter: Mitchell W. Krucoff October 27, 2025
Presentation TCT 2025 M-TEER with 4D ICE: Technology Application and Clinical Experience Presenter: Ed Quine October 27, 2025
Presentation TCT 2025 Cardiogenic Shock Working Group SCAI Definitions and Phenotypes: Why we Need Both Presenter: Navin K. Kapur October 27, 2025
Presentation TCT 2025 Update on SCAI Shock Stages: Rationale and Goals Presenter: J. Dawn Abbott October 27, 2025